Central African Republic vs Nicaragua: The number of people with susceptibility test result for rifampicin

Central African Republic
660
in 2021
Nicaragua
627
in 2021
Central African Republic rank
73rd
Nicaragua rank
74th

The number of people with susceptibility test result for rifampicin over time

  • Central African Republic
  • Nicaragua
02505007501.0k1.2k201720192021

How they compare

Central African Republic currently reports 660 against 627 in Nicaragua, a difference of 33.

That makes Central African Republic's figure about 1.1 times Nicaragua's.

The two have swapped places 1 time across 5 shared years of data; in 2017 it was Nicaragua ahead.

Central African Republic ranks 73rd and Nicaragua ranks 74th of 155 countries.

Nicaragua has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Central African Republic Nicaragua Difference Ahead
2010s 101.67 675.33 573.67 Nicaragua
2020s 665.5 944.5 279 Nicaragua

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Nicaragua?
Central African Republic, at 660 against 627 in Nicaragua as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Nicaragua?
33, with Central African Republic ahead.
How many years of comparable data are there for Central African Republic and Nicaragua?
5 years are reported by both, from 2017 to 2021.
How do Central African Republic and Nicaragua rank globally for the number of people with susceptibility test result for rifampicin?
Central African Republic ranks 73rd and Nicaragua ranks 74th of 155 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Nicaragua: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/central-african-republic/nicaragua/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/central-african-republic/nicaragua/">Central African Republic vs Nicaragua: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed